Pathophysiology and clinical management of cardiac sarcoidosis

N Hamzeh, DA Steckman, WH Sauer… - Nature reviews …, 2015 - nature.com
Cardiac sarcoidosis is a potentially life-threatening condition characterized by formation of
granulomas in the heart, resulting in conduction disturbances, atrial and ventricular …

How to Differentiate Benign versus Malignant Cardiac and Paracardiac 18F FDG Uptake at Oncologic PET/CT

AH Maurer, M Burshteyn, LP Adler, RM Steiner - Radiographics, 2011 - pubs.rsna.org
Patients undergoing 2-[fluorine 18] fluoro-2-deoxy-d-glucose (FDG) whole-body oncologic
positron emission tomography (PET)/computed tomography (CT) are studied while fasting …

[HTML][HTML] A dual tracer 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT pilot study for detection of cardiac sarcoidosis

LC Gormsen, A Haraldsen, S Kramer, AH Dias… - EJNMMI research, 2016 - Springer
Background Cardiac sarcoidosis (CS) is a potentially fatal condition lacking a single test with
acceptable diagnostic accuracy. 18 F-FDG PET/CT has emerged as a promising imaging …

[HTML][HTML] Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation

YC Toner, AA Ghotbi, S Naidu, K Sakurai… - Scientific reports, 2022 - nature.com
In recent years, cardiovascular immuno-imaging by positron emission tomography (PET)
has undergone tremendous progress in preclinical settings. Clinically, two approved PET …

Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis

N Tahara, A Tahara, Y Nitta, N Kodama… - JACC: Cardiovascular …, 2010 - jacc.org
Objectives: This study evaluated the usefulness of fasting 18F-fluorodeoxyglucose (FDG)–
positron emission tomography (PET) in the diagnosis and management of cardiac …

Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: a translational 18F-FDG PET/CT observation

M Bauckneht, G Ferrarazzo, F Fiz… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The present translational study aimed to verify whether serial 18F-FDG PET/CT predicts
doxorubicin cardiotoxicity. Methods: Fifteen athymic mice were treated intravenously with …

[HTML][HTML] Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis

M Morooka, M Moroi, K Uno, K Ito, J Wu, T Nakagawa… - EJNMMI research, 2014 - Springer
Background F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a
promising modality for detecting active lesions of cardiac sarcoidosis (CS). However …

First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease

C Nappi, M Altiero, M Imbriaco, E Nicolai… - European journal of …, 2015 - Springer
Abstract Purpose Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder
associated with severe multiorgan dysfunction and premature death. Early diagnosis and …

Assessment of myocardial perfusion and viability by positron emission tomography

C Anagnostopoulos, A Georgakopoulos… - International journal of …, 2013 - Elsevier
An important evolution has taken place recently in the field of cardiovascular Positron
Emission Tomography (PET) imaging. Being originally a highly versatile research tool that …

Is There an Association Between Clinical Presentation and the Location and Extent of Myocardial Involvement of Cardiac Sarcoidosis as Assessed by 18F …

BA Mc Ardle, DH Birnie, R Klein… - Circulation …, 2013 - Am Heart Assoc
Background—Positron emission tomography using 18F-Fluorodeoxyglucose (FDG) is an
emerging modality for diagnosis of cardiac sarcoidosis (CS). We compared the location and …